CLINICAL_TRIALS
ClinicalTrials.gov record update
Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping: an Umbrella Phase II Exploratory Clinical Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06881017
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:43.881812+00:00
- Published At
- 2025-03-18T00:00:00+00:00
- Record Updated At
- 2025-03-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Gastric Cancer", "HER2 + Gastric Cancer", "CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction", "PD-L1 Positive"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-18"- protocolSection.identificationModule.nctId
"NCT06881017"- protocolSection.identificationModule.officialTitle
"Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping: an Umbrella Phase II Exploratory Clinical Study"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.